gvtcx

NHS National Framework for low molecular weight heparin products and fondaparinux

NHS England Published 8 Aug 2023 Contracts Finder
The value below is a framework or dynamic market ceiling: the maximum that could be spent across all call-offs, not the value of a single contract. Aggregate figures on this site exclude these to avoid double counting.

key details

Value£306,140,000
Statuscomplete
Category (CPV) 33600000
Deadline3 May 2023
Procedureopen
OCIDocds-h6vhtk-03b6e3

Awards (8)

This procurement was awarded to 8 suppliers. Values shown are per-award; the notice total is £306,140,000.

SupplierValueDateStatus
Aventis Pharma ltd t/a Sanofi shared · · active
Dr.Reddy's Laboratories (UK) Limited shared · · active
LEO Pharma shared · · active
Mylan shared · · active
Pfizer Ltd shared · · active
ROVI Biotech Ltd shared · · active
Techdow Pharma England Ltd shared · · active
Tetris Pharma Ltd shared · · active

description

NHS National Framework for low molecular weight heparin products and fondaparinux<br/>Offer reference number: CM/PHR/22/5687<br/>Period of framework: 1 September 2023 to 31 August 2025 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months.

documents

Documents are linked, not mirrored. They are served by the publishing authority and may require registration.

notice history

4 notices published against this procurement.

PublishedTypeRegimeNotice
29 Mar 2023 Contract notice (F02) Earlier regulations 009091-2023
31 Mar 2023 Tender (tender) · 6b98fad7-2640-4820-a62c-5bc7bc18a25f-630678
6 Apr 2023 Corrigendum (F14) Earlier regulations 010173-2023
8 Aug 2023 Contract award notice (F03) Earlier regulations 023091-2023

more from NHS England

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.